Smart tags and a phone app could boost hepatitis c treatment success
NCT ID NCT06263829
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This trial tests a smartphone app called Tappt that uses smart tags to help people with hepatitis C stick to their daily oral medication. Participants scan tags each time they take a dose, and the app tracks adherence. The study compares their results to historical data from similar patients. The goal is to see if this simple digital tool improves medication completion and cure rates.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Tappt app (digital medication companion with smart tags)
What this could lead to
If effective, this approach could help more people with hepatitis C complete their treatment and achieve a cure, while giving pharmacists better tools to personalize care.
What could go wrong
This is a very small pilot study (5 participants) with no blinding or randomization, so results may not apply broadly. The app relies on consistent smartphone use, which may not suit everyone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATITIS C are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UIH
Chicago, Illinois, 60612, United States